Deltex Medical Group (LSE:DEMG) Interest Expense : £-0.23 Mil (TTM As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Deltex Medical Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Deltex Medical Group's interest expense for the six months ended in Dec. 2023 was £ -0.11 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was £-0.23 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Deltex Medical Group's Operating Income for the six months ended in Dec. 2023 was £ -0.44 Mil. Deltex Medical Group's Interest Expense for the six months ended in Dec. 2023 was £ -0.11 Mil. Deltex Medical Group did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Deltex Medical Group Interest Expense Historical Data

The historical data trend for Deltex Medical Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group Interest Expense Chart

Deltex Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-0.17

-0.20

-0.23

Deltex Medical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.09	-0.09	-0.11	-0.12	-0.11

Deltex Medical Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.23 Mil.

Deltex Medical Group (LSE:DEMG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Deltex Medical Group's Interest Expense for the six months ended in Dec. 2023 was £-0.11 Mil. Its Operating Income for the six months ended in Dec. 2023 was £-0.44 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was £1.78 Mil.

Deltex Medical Group's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Deltex Medical Group did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Deltex Medical Group (LSE:DEMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (LSE:DEMG) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

DTXMF:USA

Address

Terminus Road, Chichester, W Sussex, GBR, PO19 8TX

Website

https://www.deltexmedical.com/

Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (LSE:DEMG) Headlines

No Headlines